STE Stock Recent News

STE LATEST HEADLINES

STE Stock News Image - Zacks Investment Research

While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research 2024 May 08
STE Stock News Image - Zacks Investment Research

Steris (STE) came out with quarterly earnings of $2.41 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $2.30 per share a year ago.

Zacks Investment Research 2024 May 08
STE Stock News Image - Zacks Investment Research

Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Investment Research 2024 May 03
STE Stock News Image - Zacks Investment Research

STERIS' (STE) strong prospects in the healthcare and pharmaceutical industries bode well for investors.

Zacks Investment Research 2024 May 02
STE Stock News Image - GlobeNewsWire

DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.

GlobeNewsWire 2024 Apr 24
STE Stock News Image - Zacks Investment Research

STERIS (STE) is expected to have witnessed the normalization of the Healthcare backlog, as the company is currently able to ship at a faster pace than the receipt of new orders.

Zacks Investment Research 2024 Apr 22
STE Stock News Image - Zacks Investment Research

The heavy selling pressure might have exhausted for Steris (STE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks Investment Research 2024 Apr 09
STE Stock News Image - Zacks Investment Research

Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.

Zacks Investment Research 2024 Mar 28
STE Stock News Image - Zacks Investment Research

Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.

Zacks Investment Research 2024 Feb 27
STE Stock News Image - Zacks Investment Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research 2024 Feb 15
10 of 50